Literature DB >> 2432112

Propidium iodide as a nuclear counterstain for immunofluorescence studies on cells in culture.

K H Jones, D A Kniss.   

Abstract

We describe a rapid procedure using propidium iodide (PI) as a nuclear counterstain in immunofluorescence studies where cell surface or intracellular antigens are localized with fluorescein-conjugated antisera. In fixed monolayer preparations, all cell nuclei fluoresce red and can be seen simultaneously with cellular antigens that fluoresce green. Counterstaining with PI therefore makes possible quantification of the proportion of cells present in culture that stain immunocytochemically for a specific antigen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2432112     DOI: 10.1177/35.1.2432112

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  9 in total

1.  Counterstaining improves visualization of the myenteric plexus in immunolabelled whole-mount preparations.

Authors:  Parkash Mandhan; Bao Quan Qi; Jacqueline I Keenan; Salim Ismail; Spencer W Beasley; Michael J Sullivan
Journal:  J Fluoresc       Date:  2006-09-12       Impact factor: 2.217

2.  Propidium iodide enabled live imaging of Pasteuria sp.-Pratylenchus zeae infection studies under fluorescence microscopy.

Authors:  Francine Perrine-Walker; Khoa Le
Journal:  Protoplasma       Date:  2020-10-17       Impact factor: 3.356

3.  Assessment of GFP expression and viability using the tali image-based cytometer.

Authors:  Krissy Remple; Laurel Stone
Journal:  J Vis Exp       Date:  2011-11-17       Impact factor: 1.355

4.  Persistent interactions between biguanide-based compound NB325 and CXCR4 result in prolonged inhibition of human immunodeficiency virus type 1 infection.

Authors:  Nina Thakkar; Vanessa Pirrone; Shendra Passic; Shawn Keogan; Wei Zhu; Vladyslav Kholodovych; William Welsh; Robert Rando; Mohamed Labib; Brian Wigdahl; Fred C Krebs
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

5.  Next generation sequencing of DNA-launched Chikungunya vaccine virus.

Authors:  Rachmat Hidajat; Brian Nickols; Naomi Forrester; Irina Tretyakova; Scott Weaver; Peter Pushko
Journal:  Virology       Date:  2016-02-06       Impact factor: 3.616

6.  Double Labeling Fluorescent Immunocytochemistry.

Authors:  Monika Rak; Krzysztof Reiss
Journal:  Methods Mol Biol       Date:  2022

7.  DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice.

Authors:  Irina Tretyakova; Jason Hearn; Eryu Wang; Scott Weaver; Peter Pushko
Journal:  J Infect Dis       Date:  2014-02-28       Impact factor: 5.226

8.  Specific interactions between the viral coreceptor CXCR4 and the biguanide-based compound NB325 mediate inhibition of human immunodeficiency virus type 1 infection.

Authors:  Nina Thakkar; Vanessa Pirrone; Shendra Passic; Wei Zhu; Vladyslav Kholodovych; William Welsh; Robert F Rando; Mohamed E Labib; Brian Wigdahl; Fred C Krebs
Journal:  Antimicrob Agents Chemother       Date:  2008-12-01       Impact factor: 5.191

9.  Smooth muscle cells can express cytokeratins of "simple" epithelium. Immunocytochemical and biochemical studies in vitro and in vivo.

Authors:  A M Gown; H C Boyd; Y Chang; M Ferguson; B Reichler; D Tippens
Journal:  Am J Pathol       Date:  1988-08       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.